Fred Callori

Fred Callori serves as a Board Member and Co-founder at Neurosterix since 2024. Currently, Fred holds the position of Managing Director at Perceptive Advisors and Senior Partner at Xontogeny, both since 2018 and 2017, respectively. In addition, Fred is a Board Member at Catabasis Pharmaceuticals, Inc., where involvement includes prior directorship at Quellis Biosciences until its acquisition in January 2021. Fred’s board memberships extend to CereVasc and Zucara Therapeutics Inc., both of which commenced in 2020. Prior to these roles, Fred was a Partner at Choate, Hall & Stewart from 1998 to 2017. Fred earned a Doctor of Law (JD) degree from Boston University School of Law from 1991 to 1994.